Osimertinib Active Not Recruiting Phase 1 Trials for Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive Other

IndicationsStatusPurposePhase
Active Not RecruitingOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02529995Phase I, Study in Chinese NSCLC Patients